ubiquinone and Wounds-and-Injuries

ubiquinone has been researched along with Wounds-and-Injuries* in 3 studies

Trials

2 trial(s) available for ubiquinone and Wounds-and-Injuries

ArticleYear
Effect of coenzyme Q10 supplementation on oxidative stress and clinical outcomes in patients with low levels of coenzyme Q10 admitted to the intensive care unit.
    Journal of nutritional science, 2021, Volume: 10

    Today, trauma is known to be the third leading cause of death in most countries. Studies have demonstrated below-normal plasma levels of antioxidants in trauma patients. The present study aimed to assess the efficacy of Coenzyme Q10 (CoQ10) on oxidative stress, clinical outcomes and anthropometrical parameters in traumatic mechanical ventilated patients admitted to the intensive care unit. Patients were randomised to receive sublingual CoQ10 (400 mg/d) or placebo for 7 d. Primary and secondary outcomes were measured at the baseline and end of the study. We enrolled forty patients for this trial: twenty in the CoQ10 group and twenty in the placebo group. There was not any significant difference in the baseline variables (

    Topics: Antioxidants; Dietary Supplements; Glasgow Outcome Scale; Humans; Intensive Care Units; Length of Stay; Oxidative Stress; Respiration, Artificial; Ubiquinone; Wounds and Injuries

2021
The protective role of coenzyme Q10 in renal injury associated with extracorporeal shockwave lithotripsy: a randomised, placebo-controlled clinical trial.
    BJU international, 2014, Volume: 113, Issue:6

    To determine the efficacy of coenzyme Q10 (CoQ10) in preventing renal injury in patients with lithiasis undergoing extracorporeal shockwave lithotripsy (ESWL).. Prospective, randomised, double-blind, placebo-controlled clinical trial of 100 patients with renal lithiasis who were treated with ESWL. The patients were distributed randomly into two groups receiving either placebo or CoQ10 (200 mg/day), a powerful antioxidant with vasoactive properties, orally administered during the week before ESWL and for 1 week after. Renal dysfunction markers, vasoactive hormones, oxidative stress, plasma levels of several interleukins and vascular resistance index (VRI) using Doppler ultrasound were evaluated the week before ESWL, 2 h before ESWL and at 2 h, 24 h and 7 days after ESWL.. There was a significant increase in glomerular filtration (P = 0.013), as well as a decrease in the albumin/creatinine ratio and the β2 -microglobulin level (P = 0.02) after 1 week of treatment in the CoQ10 group. These changes were maintained at the follow-up after ESWL. The administration of CoQ10 was associated with improvement in vasoactive hormone parameters, VRI and interleukin levels. These improvements were maintained until the end of the follow-up period. However, the administration of CoQ10 was not associated with significant changes in the oxidative stress parameters.. Our results indicate that CoQ10 administration improves renal function and vasoactive and inflammation parameter values, allowing for preconditioning before the tissue insult caused by ESWL.

    Topics: Double-Blind Method; Female; Humans; Kidney; Kidney Calculi; Lithotripsy; Male; Middle Aged; Prospective Studies; Ubiquinone; Vitamins; Wounds and Injuries

2014

Other Studies

1 other study(ies) available for ubiquinone and Wounds-and-Injuries

ArticleYear
A Pseudomonas aeruginosa small RNA regulates chronic and acute infection.
    Nature, 2023, Volume: 618, Issue:7964

    The ability to switch between different lifestyles allows bacterial pathogens to thrive in diverse ecological niches

    Topics: Acute Disease; Anaerobiosis; Animals; Chronic Disease; Cystic Fibrosis; Genes, Bacterial; Humans; Oxygen; Pseudomonas aeruginosa; Pseudomonas Infections; RNA, Bacterial; Sepsis; Ubiquinone; Wounds and Injuries

2023